// App-Quantinova.ai

: Impact of Donor and Patient CMV Serology in Children Receiving First Geno-Identical or Unrelated HSCT for Malignant Hematological Disease: An EBMT Retrospective Registry Study

Researchers

Presenter

  • Elif Ince

Principal Investigators

  • Marianne Ifversen

  • Arnaud Dalissier

  • Zofia Szmit

  • Franco Locatelli

  • Oana Mirci-Danicar

  • Petr Sedlacek

  • Jean-Hugues Dalle

  • Mouhab Ayas

  • Rose-Marie Hamladji

  • Andrea Biondi

  • Jan Styczynski

  • Yves Bertrand

  • Elena Skorobogatova

  • Abdelghani Tbakhi

  • Katrine Kielsen

  • Vassiliki Kitra-Roussou

  • Franca Fagioli

  • Wolfgang Holter

  • Andreas H. Groll

  • Mahmoud Aljurf

  • Mervi Taskinen

  • Marc Bierings

  • Roland Meisel

  • Simone Cesaro

  • Krzysztof Kalwak

  • Selim Corbacioglu

Medical Centers

  • Onco-Ematologia Pediatrica, Centro Trapianti Cellule Staminali, Ospedale Infantile Regina Margherita, Torino, Italy

  • King Hussein Cancer Centre, Amman, Jordan

  • Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany

  • EBMT Paris Study Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs , Paris, France

  • Princess Maxima Center/ University Hospital for Children (WKZ), Stem cell transplantation, Utrecht, Netherlands

  • Pediatric Hematology and Immunology Department, Robert Debre Hospital, GHU APHP Nord-Université de Paris Cité, Paris, France

  • Hospital for Children and Adolescents, Helsinki University Hospital and Helsinki University, Helsinki, Finland

  • University Hospital, Collegium Medicum UMK Department of Pediatric Hematology and Oncology, Bydgoszcz, Poland

  • Department of Pediatric Hematology and Oncology IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy

  • Institut d`Hematologie et d`Oncologie Pediatrique,Unité de coordination interne et externe, Lyon, France

  • University Hospital Motol, Department of Paediatric Haematology And Oncology, Prague, Czech Republic

  • Department of Pediatric Hematology/Oncology and BMT Wroclaw Medical University, Wroclaw, Poland

  • Pediatric Hematology Oncology Unit, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy

  • Bristol Royal Hospital for Children, Bristol, United Kingdom

  • Copenhagen University Hospital Rigshospitalet, Department of Paediatric and Adolescent Medicine, Copenhagen, Denmark

  • Ankara University Medical Faculty, Department of Pediatric Hematology and BMT Unit, Ankara, TUR

  • Centre Pierre et Marie Curie, Alger, Algeria

  • Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

  • Pediatric Bone Marrow Transplant Unit, Fondazione MBBM -Milano Bicocca University, Monza, Italy

  • University Children's Hospital Muenster, Department of Pediatric Hematology/Oncology and Center for Bone Marrow Transplantation, Muenster, Germany

  • The Russian Children´s Research Hospital Department of Bone Marrow Transplantation, Moscow, Russian Federation

  • King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

  • Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany

  • St. Anna Kinderspital, Stem Cell Transplantation Unit, Vienna, Austria

Locations

  • Italy

  • Finland

  • Jordan

  • France

  • United Kingdom

  • Germany

  • Poland

  • Denmark

  • United States

  • Saudi Arabia

  • Turkey

  • Netherlands

  • Algeria

  • Czech Republic

  • Greece

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • pivotal

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved